Perla Cassayre Thulin
( out of 87 reviews )

Perla Cassayre Thulin, MD

Languages spoken: English

Clinical Locations

Primary Location

Imaging and Neurosciences Center

729 Arapeen Way
Salt Lake City , UT 84108
801-585-7575
Get Directions

  • Perla Cassayre Thulin, MD, has special expertise and training in the evaluation and treatment of movement disorders, including Parkinson´s disease, essential tremor, chorea, hemifacial spasm, tics, and dystonia, including torticolllis and blepharospasm, and is an expert in the use of Botox and Myobloc.

    Specialties

    Board Certification

    National Board of Medical Examiners
    American Board of Psychiatry & Neurology (Neurology)

    Patient Rating

    4.9 /5
    ( out of 87 reviews )

    The patient rating score is an average of all responses on our patient experience survey. The rating averages scores for all questions about care from our providers.

    The scale on which responses are measured is 1 to 5 with 5 being the best score.

    Patient Comments

    Patient comments are gathered from our patient experience survey and displayed in their entirety. For the convenience of our visitors, some patient comments have been translated from their original language into English while preserving their original meaning as accurately as possible. Patients are de-identified for confidentiality and patient privacy.

    CLINICAL NEUROSCIENCES CENTER

    Thank you for encouraging me. I was struggling to stay positive about having Parkinson's.

    CLINICAL NEUROSCIENCES CENTER

    Great dr.

    University Hospital

    I could not get an appointment for several months.

    University Hospital

    Dr. Thulin is caring and communicative.

    CLINICAL NEUROSCIENCES CENTER

    She is very good, I trust her with my care.

    CLINICAL NEUROSCIENCES CENTER

    Thank you Dr. Thulin for the time spent and your concern for my problems. Yu spent a lot of time and truly made the effort to understand my twitching and involuntary movements. This causes me significant pain in my neck and the base of my skull. I'm grateful for the help and am looking forward to our next visit.

    CLINICAL NEUROSCIENCES CENTER

    DR'THULIN IS OUTSTANDING IN ALL WAYS1

    CLINICAL NEUROSCIENCES CENTER

    I always have a good experience with Dr. Thulin. She never makes me feel rushed and always includes me in treatment decisions.

    CLINICAL NEUROSCIENCES CENTER

    Dr. Thulin has been very professional and personally caring about me as a patient. She has gone the extra mile to ensure a proper diagnosis is conducted and a clear understanding communicated with all concerned to ensure an effective treatment is provided.

  • Perla Cassayre Thulin, MD, has special expertise and training in the evaluation and treatment of movement disorders, including Parkinson´s disease, essential tremor, chorea, hemifacial spasm, tics, and dystonia, including torticolllis and blepharospasm, and is an expert in the use of Botox and Myobloc.

    Board Certification and Academic Information

    Academic Departments Neurology -Associate Professor (Clinical)
    Board Certification
    National Board of Medical Examiners
    American Board of Psychiatry & Neurology (Neurology)

    Education history

    Undergraduate Human Biology - Stanford University B.A.
    Professional Medical Medicine - Stanford University M.D.
    Internship Internal Medicine - Jewish Hospital of St Louis Intern
    Residency Neurology - Harvard-Longwood Neurology Resident
    Fellowship Geriatric Neurology - Portland Veterans Affairs Medical Center Fellow
    Fellowship Neurology- Movement Disorders - Oregon Health Sciences University Fellow

    Selected Publications

    Journal Article

    1. Gabriele M, Vulto-van Silfhout AT, Germain PL, Vitriolo A, Kumar R, Douglas E, Haan E, Kosaki K, Takenouchi T, Rauch A, Steindl K, Frengen E, Misceo D, Pedurupillay CRJ, Stromme P, Rosenfeld JA, Shao Y, Craigen WJ, Schaaf CP, Rodriguez-Buritica D, Farach L, Friedman J, Thulin PC McLean SD, Nugent KM, Morton J, Nicholl J, Andrieux J, Stray-Pedersen A, Chambon P, Patrier S, Lynch SA, Kjaergaard S, Tørring PM, Brasch-Andersen C, Ronan A, van Haeringen A, Anderson PJ, Powis Z, Brunner HG, Pfundt R, Schuurs-Hoeijmakers JHM, van Bon BWM, Lelieveld S, Gilissen C, Nillesen WM, Vissers LELM, Gecz J, Koolen DA, Testa G, de Vries BB (2017). YY1 Haploinsufficiency Causes an Intellectual Disability Syndrome Featuring Transcriptional and Chromatin Dysfunction. American journal of human genetics, 100(6), 907-925. (Read full publication)
    2. Coe CL, Cassayre P, Levine S, Rosenberg L (1988). Effects of age, sex, and psychological disturbance on immunoglobulin levels in the squirrel monkey. Developmental psychobiology, 21(2), 161-75. (Read full publication)
    3. Thulin PC, Woodward WR, Carter JH, Nutt J (1998). Levodopa in human breast milk: clinical implications. Neurology, 50(6), 1920-1. (Read full publication)
    4. Tarsy D, Thulin PC, Herzog A (2001). Spasmodic torticollis and reproductive function in women. Parkinsonism & related disorders, 7(4), 323-327. (Read full publication)
    5. Sweeney M, Galli J, McNally S, Tebo A, Haven T, Thulin PC, Clardy S (2017). Delayed LGI1 seropositivity in voltage-gated potassium channel (VGKC)-complex antibody limbic encephalitis. BMJ case reports, 2017, (Read full publication)
    6. Cherik F, Reilly J, Kerkhof J, Levy M, McConkey H, Barat-Houari M, Butler KM, Coubes C, Lee JA, Le Guyader G, Louie RJ, Patterson WG, Tedder ML, Bak M, Hammer TB, Craigen W, Démurger F, Dubourg C, Fradin M, Franciskovich R, Frengen E, Friedman J, Palares NR, Iascone M, Misceo D, Monin P, Odent S, Philippe C, Rouxel F, Saletti V, Strømme P, Thulin PC, Sadikovic B, Genevieve (2022). DNA methylation episignature in Gabriele-de Vries syndrome. Genetics in medicine, 24(4), 905-914. (Read full publication)
    7. Earl T, Jridi A, Thulin PC, Zorn M, McKee KE, Mitrovich K, Moretti P, Alshaikh J, Kassavetis P, Cortez MM, Lamotte (2024). Effect of levodopa on postural blood pressure changes in Parkinson disease: a randomized crossover study. Clinical autonomic research, 34(1), 117-124. (Read full publication)

    Letter

    1. Ferng A, Thulin PC, Walsh E, Weissbrod PA, Friedman (2022). YY1: A New Gene for Childhood Onset Dystonia with Prominent Oromandibular-Laryngeal Involvement?. Movement disorders, 37(1), 227-228. (Read full publication)

    Abstract

    1. Newcomb TM, Himle MB, Smart AL, Sharp AG, Viazzo-Trussell D, Thulin PC and Swoboda K (2013). Impact of Sapropterin Dihydrochloride on Mood and Motor Function in Autosomal Dominant Dopa-Responsive Dystonia (AD-DRD): A Pilot Study. Journal of inherited metabolic disease, 36(2), 91.
    2. Thulin PC, O'Brien SA, Filoteo JV, Roberts J (1999). Effect of estrogen replacement therapy on memory in women with Parkinson's disease. Movement disorders, 13, 56.
    3. Thulin PC, Nutt J (1994). Domperidone: Effects on levodopa-induced hypotension and bradycardia. Movement disorders, 9, 483-484.
    4. Thulin PC, Hammerstad J (1995). Post-traumatic torticollis and cervical radiculopathy. Movement disorders, 10, 701.
    5. Tarsy D, Thulin PC, Herzog (1997). Spasmodic Torticollis and Reproductive function. Movement disorders, 12(5), 847.
    6. Thulin PC, Carter JH, Nichols MD, Kurth M, Nutt J (1996). Menstrual cycle related changes in Parkinson's disease. Neurology, 46, A376.
    7. Thulin PC, Filoteo JV, Roberts JW, O'Brien S (1998). Effects of hormone replacement therapy on cognitive and motor function in women with Parkinson's disease. Neurology, 50(4), A280.
    8. Hills WL, Warner JEA, Katz BJ, Celune GJ, Foster NL, Steffens J, Thulin PC, Chin S, Digre KB (2008). Neuro-opthalmic findings that may reliably differentiate PSP and Parkinson's disease. 70(11):A263,
    9. Hills WL, Warner JEA, Katz BJ, Celune GJ, Foster NL, Steffens J, Thulin PC, Chin S, Digre KB (2009). Neuro-opthalmic Findings that May Reliably Differentiate PSP and Parkinson's Disease. (Platform Presentation).
    10. Hills WL, Warner JEA, Katz BJ, Celune GJ, Foster NL, Steffens J, Thulin PC, Chin S, Digre KB (2008). Differentiating Neuro-opthalmic Fndings in Progressive Supranuclear Palsy vs. Parkinson's Disease.
    11. Sweeney M, Galli J, McNally S, Tebo A, Haven T, Thulin PC, Clardy S, Department of Neurology, Department of Radiology, University of Utah, Associated and Regional University Pathologists Laboratorie (2017). The controversy surrounding voltage-gated potassium channel (VGKC)-complex antibodies: Case and Discussion.